Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
IEX Quote, Financials, Valuation and Earnings
Last price:
$183.90
Seasonality move
:
-1.19%
Day range:
$180.33 - $184.25
52-week range:
$153.36 - $238.22
Dividend yield:
1.56%
P/E ratio:
28.49x
P/S ratio:
4.16x
P/B ratio:
3.48x
Volume:
685.7K
Avg. volume:
715.5K
1-year change:
-12.61%
Market cap:
$13.6B
Revenue:
$3.3B
EPS (TTM):
$6.31
Analysts' Opinion
-
Consensus RatingIDEX has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 6 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $209.46, IDEX has an estimated upside of 16.52% from its current price of $183.96.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $180.00 representing -0.13% downside risk from its current price of $183.96.
Fair Value
-
According to the consensus of 12 analysts, IDEX has 16.52% upside to fair value with a price target of $209.46 per share.
IEX vs. S&P 500
-
Over the past 5 trading days, IDEX has underperformed the S&P 500 by -2.18% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
IDEX does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
IDEX has grown year-over-year revenues for 3 quarters straight. In the most recent quarter IDEX reported revenues of $814.3M.
Earnings Growth
-
IDEX earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter IDEX reported earnings per share of $1.26.
Enterprise value:
14.9B
EV / Invested capital:
--
Price / LTM sales:
4.16x
EV / EBIT:
22.60x
EV / Revenue:
4.55x
PEG ratio (5yr expected):
--
EV / Free cash flow:
26.76x
Price / Operating cash flow:
24.45x
Enterprise value / EBITDA:
17.66x
Gross Profit (TTM):
$1.5B
Return On Assets:
7.42%
Net Income Margin (TTM):
14.6%
Return On Equity:
12.75%
Return On Invested Capital:
8.75%
Operating Margin:
19.59%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $3.3B | $3.2B | $3.3B | $800.5M | $814.3M | |
| Gross Profit | $1.5B | $1.4B | $1.5B | $357.4M | $368.9M | |
| Operating Income | $778.8M | $712.9M | $683.7M | $162.3M | $159.5M | |
| EBITDA | $921.7M | $939.5M | $845.2M | $204.7M | $190.5M | |
| Diluted EPS | $7.72 | $7.60 | $6.31 | $1.60 | $1.26 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.7B | $1.7B | $1.5B | $1.6B | $1.6B | |
| Total Assets | $4.5B | $5B | $5.7B | $5.9B | $6.8B | |
| Current Liabilities | $377.5M | $468.3M | $491.9M | $460.6M | $583.6M | |
| Total Liabilities | $1.9B | $2.1B | $2.4B | $2.3B | $2.9B | |
| Total Equity | $2.6B | $2.9B | $3.2B | $3.6B | $3.9B | |
| Total Debt | $1B | $1.2B | $1.5B | $1.3B | $1.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $625.6M | $725.4M | $617.2M | $156.6M | $105.7M | |
| Cash From Investing | -$822M | -$274.6M | -$996.5M | -$20M | -$10M | |
| Cash From Financing | -$11.7M | -$340.5M | $373.6M | -$41M | -$133.3M | |
| Free Cash Flow | $547.1M | $642.1M | $557.8M | $136.6M | $91.4M | |
IEX
Sector
Market Cap
$13.6B
$611.3M
Price % of 52-Week High
75.46%
81.21%
Dividend Yield
1.56%
0%
Shareholder Yield
0.93%
2.28%
1-Year Price Total Return
-14.72%
-1.12%
Beta (5-Year)
1.041
0.761
Dividend yield:
1.56%
Annualized payout:
$2.71
Payout ratio:
43.67%
Growth streak:
15 years
Technicals
8-day SMA
Buy
Level
$182.23
200-day SMA
Sell
Level
$197.76
Bollinger Bands (100)
Buy
Level
172.46 - 187.94
Chaikin Money Flow
Buy
Level
540.1K
20-day SMA
Buy
Level
$178.96
Relative Strength Index (RSI14)
Buy
Level
57.17
ADX Line
Buy
Level
18.8
Williams %R
Neutral
Level
-56.9078
50-day SMA
Buy
Level
$181.55
MACD (12, 26)
Buy
Level
50.43
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
1.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.098)
Buy
CA Score
(Annual)
Level (0.6023)
Buy
Beneish M-Score
(Annual)
Level (-2.5727)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.2658)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm’s business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.
Stock Forecast FAQ
In the current month, IEX has received 6 Buy ratings 6 Hold ratings, and 0 Sell ratings. The IEX average analyst price target in the past 3 months is $209.46.
-
Where Will IDEX Stock Be In 1 Year?
According to analysts, the consensus estimate is that IDEX share price will rise to $209.46 per share over the next 12 months.
-
What Do Analysts Say About IDEX?
Analysts are divided on their view about IDEX share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that IDEX is a Sell and believe this share price will drop from its current level to $180.00.
-
What Is IDEX's Price Target?
The price target for IDEX over the next 1-year time period is forecast to be $209.46 according to 12 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is IEX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for IDEX is a Leans Bullish. 6 of 12 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of IEX?
You can purchase shares of IDEX via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase IDEX shares.
-
What Is The IDEX Share Price Today?
IDEX was last trading at $183.90 per share. This represents the most recent stock quote for IDEX. Yesterday, IDEX closed at $183.96 per share.
-
How To Buy IDEX Stock Online?
In order to purchase IDEX stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
